Table 1.

Comparison of clinical characteristics between ACP and PHN patients.

	ACP (N = 48)	PHN (N = 42)	P
Gender			1
Female	29 (60.4%)	25 (59.5%)
Male	19 (39.6%)	17 (40.5%)
Age (years)	59.3 (10.0)	69.4 (12.5)	< 0.001
Rash duration (days)	10.0 (10.5)	59.1 (54.7)	< 0.001
Rash position			0.387
Face	4 (8.3%)	7 (16.7%)
Hips	3 (6.3%)	2 (4.8%)
Lower limb	6 (12.5%)	1 (2.4%)
Lumbar	4 (8.3%)	1 (2.4%)
Lumbar/dorsum	14 (29.2%)	11 (26.2%)
Neck/Shoulder	3 (6.3%)	3 (7.1%)
Thoracodorsal	13 (27.1%)	14 (33.3%)
Upper limb	1 (2.1%)	3 (7.1%)
Pain duration (days)	49.8 (15.7)	188 (119)	< 0.001
Maximum pain time point			< 0.001
1 weeks	33 (68.8%)	9 (21.4%)
2 weeks	14 (29.2%)	17 (40.5%)
3 weeks	1 (2.1%)	14 (33.3%)
4 weeks	0 (0%)	2 (4.8%)
Rash area			< 0.001
Small	20 (41.7%)	3 (7.1%)
Median	24 (50.0%)	26 (61.9%)
Large	4 (8.3%)	13 (31.0%)
Pain level			0.807
Mild	22 (45.8%)	17 (40.5%)
Moderate	11 (22.9%)	12 (28.6%)
Severe	15 (31.3%)	13 (31.0%)
Onset month			0.263
Feb	0 (0%)	5 (11.9%)
Mar	0 (0%)	1 (2.4%)
Apr	3 (6.3%)	3 (7.1%)
May	11 (22.9%)	9 (21.4%)
Jun	7 (14.6%)	6 (14.3%)
Jul	6 (12.5%)	6 (14.3%)
Aug	0 (0%)	2 (4.8%)
Sep	13 (27.1%)	6 (14.3%)
Oct	5 (10.4%)	3 (7.1%)
Nov	1 (2.1%)	0 (0%)
Dec	2 (4.2%)	1 (2.4%)

Data presented as mean (SD) or N (ratio).